Filing Details

Accession Number:
0001156039-23-000037
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-27 16:20:15
Reporting Period:
2023-03-24
Accepted Time:
2023-03-27 16:20:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1156039 Elevance Health Inc. ELV Hospital & Medical Service Plans (6324) 352145715
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1203671 M Gloria Mccarthy 220 Virginia Avenue
Indianapolis IN 46204
Evp & Chief Administrative Off No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-03-24 600 $440.78 65,933 No 4 S Direct
Common Stock Disposition 2023-03-24 500 $442.02 65,433 No 4 S Direct
Common Stock Disposition 2023-03-24 1,800 $443.27 63,633 No 4 S Direct
Common Stock Disposition 2023-03-24 3,000 $444.33 60,633 No 4 S Direct
Common Stock Disposition 2023-03-24 5,573 $445.30 55,060 No 4 S Direct
Common Stock Disposition 2023-03-24 3,625 $446.06 51,435 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2023.
  2. This transaction was executed in multiple trades at prices ranging from $440.36 to $441.05. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $441.60 to $442.55. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $442.71 to $443.67. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $443.73 to $444.72. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades at prices ranging from $444.73 to $445.72. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  7. This transaction was executed in multiple trades at prices ranging from $445.73 to $446.42. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.